Home > Specialties > IVD Test Reagent/Kits, Molecular Assay, Gene Anomaly, Mutation, BCL6

IVD Test Reagent/Kits, Molecular Assay, Gene Anomaly, Mutation, BCL6

Definition : Molecular assay reagents intended to identify mutations in the B-cell/lymphoma 6 (BCL6) gene, located at chromosome 3q27, which functions as a transcription regulator involved in lymphogenesis. Genetic mutations (rearrangements) involving the BCL6 gene are indicators of B-cell chronic lymphocytic leukemia (B-CLL), B-cell leukemia, CLL/lymphoma 6, or B-cell non-Hodgkin's lymphoma.

Entry Terms : "Genetic Rearrangement Gene Mutation Detection Reagents" , "Lymphoma Gene Mutation Detection Reagents" , "Hodgkin's Lymphoma Gene Mutation Detection Reagents" , "Diffuse Large Cell Lymphoma (DLLC) Gene Mutation Detection Reagents" , "BCL6 Gene Mutation Detection Reagents" , "Reagents, Molecular Assay, Gene Anomaly, Mutation, BCL6"

UMDC code : 24315

Filters
Manufacturers
Distributors
U.S.companies only
Suppress Subsidiary Companies
   

1-4 of 4 Match(es).

ACROBiosystems Inc

Company Type: Parent

Cancer Diagnostics Inc

Company Type: Parent

Cancer Diagnostics, Inc. (CDI)  manufactures, develops, and supplies products for the worldwide anatomical pathology market.

Empire Genomics

Company Type: Parent

Genomind

Company Type: Parent

1-4 of 4 Match(es).

 

Medical Product Guide Optometric Management Product Guide